SUSTAINED RELEASE TABLETS OF CIPROFLOXACIN FOR THE MANAGEMENT OF BACTERIAL INFECTIONS Authors: Sahoo CK , SUBUDHI D, MISHRA A AND PRIYADARSHINI R
ABSTRACT
Sustained release (SR) tablets were developed for prolonged release of Ciprofloxacin
incorporating Hydroxypropyl methylcellulose (HPMCE5LV) as a controlled release polymer.
The current research work was to formulate SR tablets of Ciprofloxacin. Based on various
concentrations of HPMC four different batches of SR tablets of Ciprofloxacin are developed
through wet granulation process. Pre-compression plus post-compression parameters of SR
tablets are measured. Based on the highest drug release F4 was found to be the best among all
batches. The % Cumulative drug release (CDR) for F4 was 98.484 % of Ciprofloxacin at the
end of the14 hours. The drug release was prolonged due to more amount of HPMCE5LV in
F4.It is obtained from the results for all formulations that the release rate of active
pharmaceutical ingredients can be controlled through the polymer of the core as well as
following zero order kinetics. The Accelerated stability studies (ASS) confirmed that there
were insignificant alternates in evaluated parameters at the end of 3 months of F4 batch. Hence
the current technology for designing tablets can produce more advantages than conventional
tablets.
Keywords: Sustained Release, Controlled Release, Ciprofloxacin, Wet granulation Publication date: 01/12/2024 https://ijbpas.com/pdf/2024/December/MS_IJBPAS_2024_8553.pdfDownload PDFhttps://doi.org/10.31032/IJBPAS/2024/13.12.8553